Abstract

Based on early studies, current guidelines recommend renin angiotensin system (RAS) inhibitors for all patients with stable ischemic heart disease and

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call